Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof

Oral Oncology

Volumn 51, Issue 11, 2015, Pages 1004-1010

  Chen, Tseng Cheng ^a,b   Wu, Chen Tu ^a,b   Wang, Cheng Ping ^a,b   Hsu, Wan Lun ^c   Yang, Tsung Lin ^a   Lou, Pei Jen ^a   Ko, Jenq Yuh ^a   Chang, Yih Leong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Advanced stage; Disease free survivals; HIF 1 ; Magnetic resonance imaging; Metastatic lymph nodes; Oral cancer; Overall survival; PD L1 immune escape; Squamous cell carcinoma; Tumor necrosis

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROGRAMMED DEATH 1 LIGAND 1; CD274 PROTEIN, HUMAN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER CONTROL; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL SURFACE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INDUCTION CHEMOTHERAPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; NECK METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; TREATMENT OUTCOME; TUMOR NECROSIS; LYMPH NODE; METABOLISM; MOUTH TUMOR; NECK; NECROSIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD274; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK; NECROSIS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84945443762     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.08.011     Document Type: Article

References (32)

1. M.R. Posner, D.M. Hershock, C.R. Blajman, E. Mickiewicz, E. Winquist, V. Gorbounova, and et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 17 2007 1705 1715
2. T.C. Chen, C.W. Hsu, P.J. Lou, J.Y. Ko, T.L. Yang, C.N. Chen, and et al. The clinical predictive factors for subsequent distant metastasis in patients with locoregionally advanced oral squamous cell carcinoma Oral Oncol 49 4 2013 367 373
3. M.H. Yang, M.Z. Wu, S.H. Chiou, P.M. Chen, S.Y. Chang, C.J. Liu, and et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis Nat Cell Biol 10 3 2008 295 305
4. M. Pérez-Sayáns, J.M. Suárez-Peñaranda, G.D. Pilar, F. Barros-Angueira, J.M. Gándara-Rey, and A. García-García Hypoxia-inducible factors in OSCC Cancer Lett 313 1 2011 1 8
5. G.L. Semenza Targeting HIF-1 for cancer therapy Nat Rev Cancer 3 10 2003 721 732
6. H. Dong, S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, and et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 8 2002 793 800
7. J. Zhang, W. Fang, T. Qin, Y. Yang, S. Hong, W. Liang, and et al. Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma Med Oncol 32 3 2015 86
8. A. Wang, H.Y. Wang, Y. Liu, M.C. Zhao, H.J. Zhang, Z.Y. Lu, and et al. The prognostic value of PD-L1 expression for non-small cell lung cancer patients: a meta-analysis Eur J Surg Oncol 41 4 2015 450 456
9. S. Lyford-Pike, S. Peng, G.D. Young, J.M. Taube, W.H. Westra, B. Akpeng, and et al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma Cancer Res 73 6 2013 1733 1741
10. Malm IJ, Bruno TC, Fu J, Zeng Q, Taube JM, Westra W, et al. Expression profile and in vitro blockade of programmed death-1 in human papillomavirus-negative head and neck squamous cell carcinoma. Head Neck. 2014 April 7.
11. J.R. Brahmer, S.S. Tykodi, L.Q. Chow, W.J. Hwu, S.L. Topalian, P. Hwu, and et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer N Engl J Med 366 26 2012 2455 2465
12. S.L. Topalian, F.S. Hodi, J.R. Brahmer, S.N. Gettinger, D.C. Smith, D.F. McDermott, and et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer N Engl J Med 366 26 2012 2443 2454
13. R.S. Herbst, J.C. Soria, M. Kowanetz, G.D. Fine, O. Hamid, M.S. Gordon, and et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients Nature 515 7528 2014 563 567
14. S.P. Patel, and R. Kurzrock PD-L1 expression as a predictive biomarker in cancer immunotherapy Mol Cancer Ther 14 4 2015 847 856
15. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti, and et al. AJCC cancer staging manual 7th ed. 2010 Springer New York
16. Pindborg JJ RP, Smith CJ, Waal I van der. World Health Organisation histological typing of cancer and precancer of the oral mucosa. 1997.
17. A.D. King, G.M. Tse, A.T. Ahuja, E.H. Yuen, A.C. Vlantis, E.W. To, and et al. Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US Radiology 230 3 2004 720 726
18. K. Kishimoto, S. Yoshida, S. Ibaragi, N. Yoshioka, T. Okui, G.F. Hu, and et al. Hypoxia-induced up-regulation of angiogenin, besides VEGF, is related to progression of oral cancer Oral Oncol 48 11 2012 1120 1127
19. J.M. Taube, R.A. Anders, G.D. Young, H. Xu, R. Sharma, T.L. McMiller, and et al. Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape Sci Transl Med 4 127 2012 127ra37
20. C. Peitzsch, R. Perrin, R.P. Hill, A. Dubrovska, and I. Kurth Hypoxia as a biomarker for radioresistant cancer stem cells Int J Radiat Biol 90 8 2014 636 652
21. S. Yoshiba, D. Ito, T. Nagumo, T. Shirota, M. Hatori, and S. Shintani Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest Oral Oncol 45 2 2009 109 115
22. C.W. Pugh, and P.J. Ratcliffe Regulation of angiogenesis by hypoxia: role of the HIF system Nat Med 9 6 2003 677 684
23. A.W. Eckert, M.H. Lautner, A. Schütze, K. Bolte, M. Bache, M. Kappler, and et al. Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients J Oral Pathol Med 39 4 2010 313 317
24. A.W. Eckert, M.H. Lautner, A. Schütze, H. Taubert, J. Schubert, and U. Bilkenroth Coexpression of hypoxia-inducible factor-1alpha and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients Histopathology 58 7 2011 1136 1147
25. A.W. Eckert, A. Schutze, M.H. Lautner, H. Taubert, J. Schubert, and U. Bilkenroth HIF-1alpha is a prognostic marker in oral squamous cell carcinomas Int J Biol Markers 25 2 2010 87 92
26. W.M. Tilakaratne, and E.H. Nissanka-Jayasuriya Value of HIF-1α as an independent prognostic indicator in oral squamous cell carcinoma Expert Rev Mol Diagn 11 2 2011 145 147
27. J.W. Lee, S.H. Bae, J.W. Jeong, S.H. Kim, and K.W. Kim Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions Exp Mol Med 36 1 2004 1 12
28. I.B. Barsoum, C.A. Smallwood, D.R. Siemens, and C.H. Graham A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells Cancer Res 74 3 2014 665 674
29. M.Z. Noman, G. Desantis, B. Janji, M. Hasmim, S. Karray, P. Dessen, and et al. PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation J Exp Med 211 5 2014 781 790
30. T. Azuma, S. Yao, G. Zhu, A.S. Flies, S.J. Flies, and L. Chen B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells Blood 111 7 2008 3635 3643
31. M. Sznol, and L. Chen Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer Clin Cancer Res 19 5 2013 1021 1034
32. M. Song, D. Chen, B. Lu, C. Wang, J. Zhang, L. Huang, and et al. PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer PLoS ONE 8 6 2013 e65821